Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
43.80
-0.45 (-1.02%)
At close: Jun 15, 2026, 4:00 PM EDT
43.83
+0.03 (0.07%)
After-hours: Jun 15, 2026, 7:32 PM EDT

Sanofi Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Sanofi stock has a consensus rating of "Buy" and an average price target of $55.9. The average 1-year stock price forecast is 27.63% higher than the current stock price, while the lowest is $51 (+16.44%) and the highest is $63 (+43.84%).

Price Target: $55.9 (+27.63%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$51$55.9$54.5$63
Change+16.44%+27.63%+24.43%+43.84%
* Price targets were last updated on May 1, 2026.

Analyst Ratings

The average analyst rating for Sanofi stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy544444
Buy333211
Hold233455
Sell000000
Strong Sell000000
Total101010101010

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Hold
Downgrades
$55$52
HoldDowngrades$55$52+18.72%May 1, 2026
TD Cowen
TD Cowen
Hold
Reiterates
$57
HoldReiterates$57+30.14%Apr 23, 2026
Exane BNP Paribas
Exane BNP Paribas
Hold
Downgrades
$50
HoldDowngrades$50+14.16%Apr 20, 2026
Unknown Analyst
Berenberg Bank
No rating
Berenberg Bank
Buy
Maintains
$62
BuyMaintains$62+41.55%Jan 21, 2026
Barclays
Barclays
Hold
Downgrades
n/a
HoldDowngradesn/an/aJan 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
47.07B
from 46.72B
Increased by 0.75%
Revenue Next Year
49.98B
from 47.07B
Increased by 6.19%
EPS This Year
8.51
from 7.83
Increased by 8.70%
EPS Next Year
9.01
from 8.51
Increased by 5.87%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
39.18B40.30B41.11B44.29B46.72B47.07B
Revenue Growth
4.83%2.88%2.00%7.73%5.49%0.75%
Gross Profit
26.92B28.44B28.49B31.09B33.79B35.13B
Gross Margin
68.73%70.55%69.30%70.21%72.34%74.63%
Operating Income
8.57B10.38B8.12B8.87B9.65B12.83B
Net Income
6.22B8.37B5.40B5.56B7.81B8.15B
EPS
----7.838.51
EPS Growth
----9.97%8.70%
Forward PE
-----8.88
Dividend / Share
3.333.563.763.924.124.26
Dividend Growth
-6.91%5.62%4.26%5.10%3.30%
Free Cash Flow
7.34B8.51B7.17B-4.94B16.64B8.59B
No. Analysts
-----10
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High49.3B
Avg47.1B
Low46.2B

Revenue Growth

Revenue Growth202620272028
High
5.6%
Avg
0.8%
Low
-1.1%

EPS Forecast

EPS202620272028
High9.19
Avg8.51
Low8.06

EPS Growth

EPS Growth202620272028
High
17.4%
Avg
8.7%
Low
3.0%